Annual EBITDA
-$14.83 M
-$43.56 M-151.60%
31 December 2023
Summary:
ProPhase Labs annual earnings before interest, taxes, depreciation & amortization is currently -$14.83 million, with the most recent change of -$43.56 million (-151.60%) on 31 December 2023. During the last 3 years, it has fallen by -$13.27 million (-849.84%). PRPH annual EBITDA is now -142.24% below its all-time high of $35.10 million, reached on 31 December 1997.PRPH EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$5.43 M
+$637.00 K+10.50%
30 September 2024
Summary:
ProPhase Labs quarterly earnings before interest, taxes, depreciation & amortization is currently -$5.43 million, with the most recent change of +$637.00 thousand (+10.50%) on 30 September 2024. Over the past year, it has dropped by -$825.00 thousand (-17.91%). PRPH quarterly EBITDA is now -131.08% below its all-time high of $17.48 million, reached on 31 March 2022.PRPH Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$27.25 M
-$825.00 K-3.12%
30 September 2024
Summary:
ProPhase Labs TTM earnings before interest, taxes, depreciation & amortization is currently -$27.25 million, with the most recent change of -$825.00 thousand (-3.12%) on 30 September 2024. Over the past year, it has dropped by -$17.61 million (-182.73%). PRPH TTM EBITDA is now -162.01% below its all-time high of $43.95 million, reached on 30 September 2022.PRPH TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PRPH EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -151.6% | -17.9% | -182.7% |
| 3 y3 years | -849.8% | -103.0% | -1552.6% |
| 5 y5 years | -1085.2% | -1404.4% | -879.9% |
PRPH EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -151.6% | at low | -131.1% | +41.2% | -162.0% | at low |
| 5 y | 5 years | -151.6% | at low | -131.1% | +41.2% | -162.0% | at low |
| alltime | all time | -142.2% | at low | -131.1% | +41.2% | -162.0% | at low |
ProPhase Labs EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$5.43 M(-10.5%) | -$27.25 M(+3.1%) |
| June 2024 | - | -$6.07 M(-6.9%) | -$26.43 M(+12.4%) |
| Mar 2024 | - | -$6.52 M(-29.4%) | -$23.50 M(+58.5%) |
| Dec 2023 | -$14.83 M(-151.6%) | -$9.23 M(+100.5%) | -$14.83 M(+53.8%) |
| Sept 2023 | - | -$4.61 M(+46.5%) | -$9.64 M(+469.3%) |
| June 2023 | - | -$3.14 M(-245.8%) | -$1.69 M(-112.6%) |
| Mar 2023 | - | $2.16 M(-153.3%) | $13.41 M(-53.3%) |
| Dec 2022 | $28.73 M(+186.9%) | -$4.04 M(-221.1%) | $28.73 M(-34.6%) |
| Sept 2022 | - | $3.34 M(-72.1%) | $43.95 M(+15.9%) |
| June 2022 | - | $11.96 M(-31.5%) | $37.93 M(+48.4%) |
| Mar 2022 | - | $17.48 M(+56.4%) | $25.56 M(+155.2%) |
| Dec 2021 | $10.02 M(-741.6%) | $11.17 M(-517.5%) | $10.02 M(-707.4%) |
| Sept 2021 | - | -$2.68 M(+555.9%) | -$1.65 M(-402.0%) |
| June 2021 | - | -$408.00 K(-121.2%) | $546.00 K(-50.8%) |
| Mar 2021 | - | $1.93 M(-490.5%) | $1.11 M(-171.7%) |
| Dec 2020 | -$1.56 M(-42.4%) | -$494.00 K(+2.7%) | -$1.55 M(+19.9%) |
| Sept 2020 | - | -$481.00 K(-410.3%) | -$1.29 M(+10.3%) |
| June 2020 | - | $155.00 K(-121.3%) | -$1.17 M(-53.0%) |
| Mar 2020 | - | -$727.00 K(+206.8%) | -$2.49 M(-8.0%) |
| Dec 2019 | -$2.71 M(+116.5%) | -$237.00 K(-34.3%) | -$2.71 M(-2.6%) |
| Sept 2019 | - | -$361.00 K(-69.1%) | -$2.78 M(-14.0%) |
| June 2019 | - | -$1.17 M(+23.8%) | -$3.23 M(+44.6%) |
| Mar 2019 | - | -$943.00 K(+204.2%) | -$2.24 M(+78.7%) |
| Dec 2018 | -$1.25 M(-65.8%) | -$310.00 K(-62.0%) | -$1.25 M(-1.7%) |
| Sept 2018 | - | -$815.00 K(+382.2%) | -$1.27 M(+1.5%) |
| June 2018 | - | -$169.00 K(-502.4%) | -$1.25 M(-51.7%) |
| Mar 2018 | - | $42.00 K(-112.7%) | -$2.60 M(-24.9%) |
| Dec 2017 | -$3.65 M(+8.5%) | -$332.00 K(-58.3%) | -$3.46 M(-2.6%) |
| Sept 2017 | - | -$796.00 K(-47.5%) | -$3.56 M(+4.9%) |
| June 2017 | - | -$1.51 M(+84.5%) | -$3.39 M(+11.5%) |
| Mar 2017 | - | -$821.00 K(+93.2%) | -$3.04 M(-9.7%) |
| Dec 2016 | -$3.37 M(+97.0%) | -$425.00 K(-32.4%) | -$3.37 M(+31.0%) |
| Sept 2016 | - | -$629.00 K(-46.1%) | -$2.57 M(+106.4%) |
| June 2016 | - | -$1.17 M(+1.7%) | -$1.25 M(-20.2%) |
| Mar 2016 | - | -$1.15 M(-408.3%) | -$1.56 M(-8.7%) |
| Dec 2015 | -$1.71 M(-77.4%) | $372.00 K(-46.6%) | -$1.71 M(-72.7%) |
| Sept 2015 | - | $696.00 K(-147.0%) | -$6.25 M(-4.1%) |
| June 2015 | - | -$1.48 M(+14.4%) | -$6.52 M(-19.6%) |
| Mar 2015 | - | -$1.30 M(-68.9%) | -$8.11 M(+7.4%) |
| Dec 2014 | -$7.55 M(-1241.8%) | -$4.17 M(-1068.0%) | -$7.55 M(+178.7%) |
| Sept 2014 | - | $431.00 K(-114.0%) | -$2.71 M(+47.0%) |
| June 2014 | - | -$3.07 M(+315.7%) | -$1.84 M(+325.4%) |
| Mar 2014 | - | -$738.00 K(-210.6%) | -$433.00 K(-165.6%) |
| Dec 2013 | $661.00 K(-178.8%) | $667.00 K(-48.6%) | $660.00 K(+28.2%) |
| Sept 2013 | - | $1.30 M(-178.2%) | $515.00 K(+43.9%) |
| June 2013 | - | -$1.66 M(-567.3%) | $358.00 K(+141.9%) |
| Mar 2013 | - | $355.00 K(-32.0%) | $148.00 K(-117.6%) |
| Dec 2012 | -$839.00 K(-64.4%) | $522.00 K(-54.2%) | -$839.00 K(-73.0%) |
| Sept 2012 | - | $1.14 M(-161.0%) | -$3.11 M(+2.3%) |
| June 2012 | - | -$1.87 M(+195.7%) | -$3.04 M(+47.8%) |
| Mar 2012 | - | -$632.00 K(-63.9%) | -$2.06 M(-12.6%) |
| Dec 2011 | -$2.35 M(-27.1%) | -$1.75 M(-244.7%) | -$2.35 M(+39.3%) |
| Sept 2011 | - | $1.21 M(-236.5%) | -$1.69 M(-9.4%) |
| June 2011 | - | -$886.00 K(-4.5%) | -$1.87 M(-41.2%) |
| Mar 2011 | - | -$928.00 K(-14.5%) | -$3.17 M(-1.7%) |
| Dec 2010 | -$3.23 M | -$1.08 M(-205.0%) | -$3.23 M(+860.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2010 | - | $1.03 M(-147.1%) | -$336.00 K(+460.0%) |
| June 2010 | - | -$2.19 M(+123.3%) | -$60.00 K(-97.4%) |
| Mar 2010 | - | -$982.00 K(-154.4%) | -$2.34 M(-31.4%) |
| Dec 2009 | -$3.41 M(-43.0%) | $1.81 M(+38.0%) | -$3.41 M(-52.7%) |
| Sept 2009 | - | $1.31 M(-129.3%) | -$7.22 M(-6.4%) |
| June 2009 | - | -$4.47 M(+117.9%) | -$7.71 M(+24.4%) |
| Mar 2009 | - | -$2.05 M(+2.7%) | -$6.20 M(-7.8%) |
| Dec 2008 | -$5.98 M(+285.6%) | -$2.00 M(-345.5%) | -$6.73 M(+165.9%) |
| Sept 2008 | - | $814.00 K(-127.5%) | -$2.53 M(+15.8%) |
| June 2008 | - | -$2.96 M(+14.8%) | -$2.19 M(-23.1%) |
| Mar 2008 | - | -$2.58 M(-217.4%) | -$2.84 M(+34.7%) |
| Dec 2007 | -$1.55 M(-1052.6%) | $2.20 M(+89.9%) | -$2.11 M(+4.3%) |
| Sept 2007 | - | $1.16 M(-132.0%) | -$2.02 M(-11.7%) |
| June 2007 | - | -$3.62 M(+95.7%) | -$2.29 M(+63.7%) |
| Mar 2007 | - | -$1.85 M(-180.9%) | -$1.40 M(+20.3%) |
| Dec 2006 | $162.90 K(-96.3%) | $2.29 M(+157.0%) | -$1.16 M(-12.4%) |
| Sept 2006 | - | $889.70 K(-132.6%) | -$1.33 M(-291.3%) |
| June 2006 | - | -$2.73 M(+69.1%) | $694.90 K(-55.5%) |
| Mar 2006 | - | -$1.61 M(-176.0%) | $1.56 M(-47.6%) |
| Dec 2005 | $4.38 M(+443.8%) | $2.12 M(-27.2%) | $2.98 M(+5.2%) |
| Sept 2005 | - | $2.91 M(-256.6%) | $2.83 M(+333.1%) |
| June 2005 | - | -$1.86 M(+854.5%) | $653.90 K(-59.2%) |
| Mar 2005 | - | -$194.90 K(-109.9%) | $1.60 M(+60.8%) |
| Dec 2004 | $806.10 K(-27.3%) | $1.97 M(+168.3%) | $996.40 K(-35.7%) |
| Sept 2004 | - | $735.60 K(-180.6%) | $1.55 M(+66.8%) |
| June 2004 | - | -$912.50 K(+14.0%) | $929.00 K(+22.7%) |
| Mar 2004 | - | -$800.30 K(-131.7%) | $757.30 K(+19.2%) |
| Dec 2003 | $1.11 M(-122.7%) | $2.53 M(+2093.2%) | $635.50 K(-117.2%) |
| Sept 2003 | - | $115.20 K(-110.6%) | -$3.70 M(-10.8%) |
| June 2003 | - | -$1.08 M(+17.6%) | -$4.14 M(-8.9%) |
| Mar 2003 | - | -$922.10 K(-49.0%) | -$4.55 M(-15.8%) |
| Dec 2002 | -$4.88 M(-574.3%) | -$1.81 M(+446.7%) | -$5.40 M(+1652.3%) |
| Sept 2002 | - | -$330.70 K(-77.8%) | -$308.20 K(-4102.6%) |
| June 2002 | - | -$1.49 M(-16.1%) | $7700.00(-101.2%) |
| Mar 2002 | - | -$1.77 M(-154.0%) | -$649.70 K(-214.1%) |
| Dec 2001 | $1.03 M(-119.2%) | $3.28 M(<-9900.0%) | $569.20 K(-123.2%) |
| Sept 2001 | - | -$14.80 K(-99.3%) | -$2.45 M(-1.9%) |
| June 2001 | - | -$2.15 M(+286.4%) | -$2.50 M(+15.5%) |
| Mar 2001 | - | -$555.20 K(-309.2%) | -$2.16 M(-62.1%) |
| Dec 2000 | -$5.35 M(-21.1%) | $265.40 K(-527.4%) | -$5.71 M(-23.4%) |
| Sept 2000 | - | -$62.10 K(-96.6%) | -$7.45 M(-1.8%) |
| June 2000 | - | -$1.81 M(-55.8%) | -$7.59 M(-2.9%) |
| Mar 2000 | - | -$4.10 M(+176.9%) | -$7.82 M(+8.9%) |
| Dec 1999 | -$6.78 M(-168.8%) | -$1.48 M(+640.0%) | -$7.18 M(+289.0%) |
| Sept 1999 | - | -$200.00 K(-90.2%) | -$1.85 M(-164.7%) |
| June 1999 | - | -$2.04 M(-41.2%) | $2.85 M(-36.4%) |
| Mar 1999 | - | -$3.46 M(-189.9%) | $4.49 M(-53.5%) |
| Dec 1998 | $9.85 M(-71.9%) | $3.85 M(-14.4%) | $9.65 M(-53.4%) |
| Sept 1998 | - | $4.50 M(-1225.0%) | $20.70 M(-12.3%) |
| June 1998 | - | -$400.00 K(-123.5%) | $23.60 M(-8.5%) |
| Mar 1998 | - | $1.70 M(-88.6%) | $25.80 M(-26.3%) |
| Dec 1997 | $35.10 M(-5114.3%) | $14.90 M(+101.4%) | $35.00 M(+74.1%) |
| Sept 1997 | - | $7.40 M(+311.1%) | $20.10 M(+58.3%) |
| June 1997 | - | $1.80 M(-83.5%) | $12.70 M(+16.5%) |
| Mar 1997 | - | $10.90 M | $10.90 M |
| Dec 1996 | -$700.00 K | - | - |
FAQ
- What is ProPhase Labs annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for ProPhase Labs?
- What is ProPhase Labs annual EBITDA year-on-year change?
- What is ProPhase Labs quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for ProPhase Labs?
- What is ProPhase Labs quarterly EBITDA year-on-year change?
- What is ProPhase Labs TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for ProPhase Labs?
- What is ProPhase Labs TTM EBITDA year-on-year change?
What is ProPhase Labs annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of PRPH is -$14.83 M
What is the all time high annual EBITDA for ProPhase Labs?
ProPhase Labs all-time high annual earnings before interest, taxes, depreciation & amortization is $35.10 M
What is ProPhase Labs annual EBITDA year-on-year change?
Over the past year, PRPH annual earnings before interest, taxes, depreciation & amortization has changed by -$43.56 M (-151.60%)
What is ProPhase Labs quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of PRPH is -$5.43 M
What is the all time high quarterly EBITDA for ProPhase Labs?
ProPhase Labs all-time high quarterly earnings before interest, taxes, depreciation & amortization is $17.48 M
What is ProPhase Labs quarterly EBITDA year-on-year change?
Over the past year, PRPH quarterly earnings before interest, taxes, depreciation & amortization has changed by -$825.00 K (-17.91%)
What is ProPhase Labs TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of PRPH is -$27.25 M
What is the all time high TTM EBITDA for ProPhase Labs?
ProPhase Labs all-time high TTM earnings before interest, taxes, depreciation & amortization is $43.95 M
What is ProPhase Labs TTM EBITDA year-on-year change?
Over the past year, PRPH TTM earnings before interest, taxes, depreciation & amortization has changed by -$17.61 M (-182.73%)